biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > PLX vol. 2.5 million shares with only 50 million outstanding

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Feb 24, 2023 2:03pm

52 Views

Post# 35303949

RE:RE:RE:RE:RE:PLX vol. 2.5 million shares with only 50 million outstanding

it's been 3 years and there has been no updates on any progress between bti and chiesi. bti has no money. the stock is trading at $.01. they can't pay their debt obligations and recently tried to sell the company for nothing to another company that was bankrupt. now remind me about this great deal bti has in place with chiesi. why isn't chiesi trying to buy bti out for peanuts so they can own the platform and not have to pay any royalities/milestones? huh? can you answer that question prophetofabsurdity??

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market